Abstract

e19538Background: Erythropoiesis-stimulating agents (ESAs), such as erythropoietin (EPO) and novel erythropoiesis stimulating protein (NESP), may alleviate anemia in diffuse large B-cell lymphoma (...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Current and Upcoming Erythropoiesis-Stimulating Agents, Iron Products, and Other Novel Anemia Medications
Iain C Macdougall ... Michael Ashenden
Advances in renal replacement therapy | VOL. 16
Iain C Macdougall, et. al.Iain C Macdougall ... Michael Ashenden
20 Feb 2009
The Effect of Erythropoiesis-Stimulating Agent on the Management of Chemotherapy-Induced Anemia and Tumor Growth in Diffuse Large B-Cell Lymphoma Patients
Lee Chun Park ... Young Rok Do
Blood | VOL. 130
Lee Chun Park, et. al.Lee Chun Park ... Young Rok Do
25 Jun 2021
The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patients.
Lee Chun Park ... Sung Yong Oh
Radiation oncology investigations | VOL. 145
Lee Chun Park, et. al.Lee Chun Park ... Sung Yong Oh
06 May 2019
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.
J Glaspy ... G Justice
British journal of cancer | VOL. Suppl 84 1
J Glaspy, et. al.J Glaspy ... G Justice
01 Apr 2001
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy.
Mark Y Jeng ... Helena A Yu
Journal of Clinical Oncology | VOL. 42
Mark Y Jeng, et. al.Mark Y Jeng ... Helena A Yu
10 Aug 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott ... Sepideh Gholami
Journal of Clinical Oncology | VOL. -
Aaron J Scott, et. al.Aaron J Scott ... Sepideh Gholami
08 Aug 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Jordan R Hansford ... Eric Bouffet
Journal of Clinical Oncology | VOL. -
Jordan R Hansford, et. al.Jordan R Hansford ... Eric Bouffet
07 Aug 2024
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.
Rik J Verheijden ... Karijn P M Suijkerbuijk
Journal of Clinical Oncology | VOL. -
Rik J Verheijden, et. al.Rik J Verheijden ... Karijn P M Suijkerbuijk
07 Aug 2024
View more papers